Kennedy Capital Management LLC Purchases 141,174 Shares of OrthoPediatrics Corp. (NASDAQ:KIDS)

Kennedy Capital Management LLC lifted its holdings in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 129.8% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 249,978 shares of the company’s stock after buying an additional 141,174 shares during the period. Kennedy Capital Management LLC’s holdings in OrthoPediatrics were worth $5,794,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. Quarry LP bought a new position in OrthoPediatrics during the third quarter worth $25,000. R Squared Ltd acquired a new stake in OrthoPediatrics during the fourth quarter worth about $48,000. KLP Kapitalforvaltning AS acquired a new position in OrthoPediatrics during the fourth quarter valued at approximately $79,000. BNP Paribas Financial Markets lifted its position in shares of OrthoPediatrics by 125.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock worth $94,000 after buying an additional 1,929 shares during the last quarter. Finally, AlphaCentric Advisors LLC bought a new position in OrthoPediatrics in the 4th quarter valued at approximately $171,000. 69.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently weighed in on the company. Truist Financial lowered their target price on OrthoPediatrics from $26.00 to $24.00 and set a “hold” rating for the company in a research report on Friday. Stifel Nicolaus cut their price objective on shares of OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating on the stock in a report on Wednesday, March 5th. Lake Street Capital started coverage on OrthoPediatrics in a research report on Monday, April 7th. They issued a “buy” rating and a $37.00 price objective on the stock. Finally, Needham & Company LLC restated a “buy” rating and issued a $42.00 target price on shares of OrthoPediatrics in a research note on Wednesday. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $37.00.

OrthoPediatrics Stock Down 1.1 %

KIDS opened at $21.16 on Friday. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68. OrthoPediatrics Corp. has a one year low of $20.78 and a one year high of $35.99. The firm has a market capitalization of $513.91 million, a P/E ratio of -17.20 and a beta of 1.17. The company has a fifty day moving average price of $24.20 and a 200-day moving average price of $24.76.

OrthoPediatrics (NASDAQ:KIDS) last announced its earnings results on Tuesday, March 4th. The company reported ($0.29) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.04. The business had revenue of $52.67 million for the quarter, compared to analyst estimates of $51.16 million. OrthoPediatrics had a negative return on equity of 5.78% and a negative net margin of 15.00%. During the same period in the prior year, the company earned ($0.23) EPS. Equities research analysts expect that OrthoPediatrics Corp. will post -0.93 earnings per share for the current fiscal year.

Insider Activity at OrthoPediatrics

In other news, General Counsel Daniel J. Gerritzen sold 5,310 shares of the company’s stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total value of $132,006.60. Following the completion of the transaction, the general counsel now directly owns 110,767 shares in the company, valued at approximately $2,753,667.62. This represents a 4.57 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Gregory A. Odle sold 5,359 shares of the stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total value of $133,224.74. Following the transaction, the insider now owns 148,788 shares in the company, valued at $3,698,869.68. This trade represents a 3.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 23,732 shares of company stock valued at $589,978 over the last three months. 31.80% of the stock is owned by corporate insiders.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.